Results 281 to 290 of about 495,708 (385)

How Placebos Change the Patient's Brain

Neuropsychopharmacology, 2011
F. Benedetti, E. Carlino, A. Pollo
semanticscholar   +1 more source

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, Sanman Ghorpade, Caroline Easterbrook, Marcin Zabielski, Oscar Della Pasqua   +6 more
wiley   +1 more source

Justice for Placebo: Placebo Effect in Clinical Trials and Everyday Practice. [PDF]

Medicines (Basel)
Knezevic NN, Sic A, Worobey S, Knezevic E.   +3 more
europepmc   +1 more source

Chlorhexidine mouthwash and augmentin to prevent Alveolar Osteitis after removal of mandibular third molar: a three-arm placebo- controlled randomized clinical trial

Salah Sakka, Mohamed Yaser Kharma, Ali Al Rafedah   +2 more
openalex   +2 more sources

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

, 2019
Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta, Lawrence A. Leiter, Tabassome Simon, Kim Fox, Claes Held, Marielle Andersson, Anders Himmelmänn, Wilhelm Ridderstråle, Yang Song, Rafael Díaz, Shinya Goto, Stefan James, Kausik K. Ray, Alexander Parkhomenko, Mikhail Kosiborod, Darren K. McGuire, Robert A Harrington, Vladimir Santos, Ashit Jain, Irina Lendel, Michael Russo, W. Herbert Haught, Manuel Bouza, Harinder Gogia, Supratim Banerjee, George Kichura, Louis Kantaros, Francisco Padrón, R. Passi, Jay Stone, Michael Pursley, Michael D'Urso, Timothy J. Gardner, James Bennett, Khaled Nour, Satinder Saini, Wenwu Zhang, Dharam J. Kumbhani, Dustin Thomas, Dominick J. Angiolillo, Barry Bertolet, Amaury Roman-Miranda, Robert Black, Ramin Manshadi, Carlos Vaca, Antonio Blanco, Mark Napoli, David Brabham, Ayim Akyea-Djamson, Pratik Desai, Sudhir Prasada, Ajit S Khaira, Leslie B. Forgosh, Ira Lieber, Guillermo E. Umpierrez, Dinesh Singal, Juan Luis Londoño, Neil Fraser, Juan Manuel García‐Ruiz, Damaris Vega, Lilia Rodriguez, Christopher Brown, Faizullah Syed, Guarav Aggarwala, William Eaves, Michael Foster, Dinesh Gupta, David Avino, Wail Asfour, Glen Tonnessen, Xue‐Qiao Zhao, Narendra Singh, Andrew Brockmyre, Norman Lepor, Nicolas W. Shammas, David R. Blick, Steven Hearne, John Prodafikas, Edgar S. Carell, Mark Izzo, Amin H. Karim, Bosh Zakhary, Mahmoud Atieh, Steven B. Leichter, Charles Meadows, David R. Hotchkiss, Mazen Abu-Fadel, Alan Wiseman, Jeffrey Bander, Mahesh Shah, Subhash Banerjee, Ricky Ganim, Karen S Sopko, Misal Khan, Ramon L. Lloret, Troy Weirick, Rajendra H. Mehta, Udho Thadani   +99 more
openalex   +2 more sources

Drugs and placebos: what's the difference?

EMBO Reports, 2014
F. Benedetti
semanticscholar   +1 more source

Low‐intervention clinical trials in Spain: Do they progress?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Low‐Intervention Clinical Trials (LICTs) are generally pragmatic trials that investigate medicinal products already authorized for use. In 2014, simplified regulatory frameworks were introduced for LICTs with the aim of reducing regulatory burden and operational complexity, to foster non‐commercial clinical trials (NCCTs); the mandatory ...
Claudia Erika Delgado‐Espinoza, Mayro J. Cortés Pestana, Kristopher Amaro, Rosa M. Antonijoan, Caridad Pontes   +4 more
wiley   +1 more source

What are set and setting: Reducing vagueness to improve research and clinical practice. [PDF]

J Psychopharmacol
Patch K, Smith WR.
europepmc   +1 more source

[Book Review of] \u3cem\u3eImplications of History and Ethics to Medicine: Veterinary and Human\u3c/em\u3e, edited by Lawrence B. McCullough and James Polk Morris, III [PDF]

, 1979
Benjamin, Walter W.
core   +1 more source

Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study

, 2019
Mahendra P. Kapoor, Koji Suzuki, Timm Derek, Makoto Ozeki, Tsutomu Ōkubo   +4 more
openalex   +1 more source